New drug launch prices have doubled since 2005

The launch prices for new drugs have doubled since 2005, in part because of the way Medicare reimburses physicians and other providers for Medicare Part B drugs, according to an analysis from Durham, N.C.-based Duke University's Fuqua School of Business.